Page results
-
The Royal National Ear Nose and Throat Hospital is a national and international centre for voice disorders. The voice service includes four consultant laryngologists, eight speech and language therapists and specialist nurses.
-
On 13 January 2020, a consultation which asks for people’s views on the future of planned orthopaedic surgery for adults in north central London was launched.
-
The Charles Dent Metabolic Unit (CDMU) is one of the largest and longest established services in the world for the treatment of adolescents and adults (aged 16 years and older) with inherited metabolic diseases.
-
This page provides information about a new way of diagnosing and treating disorders of the pancreas, pancreatic duct and bile ducts.
-
The head and neck speech and language therapy team provide a highly specialist service to both inpatients and outpatients who may experience difficulty swallowing or speaking following treatment for head and neck cancer.
-
A clinic for neurology patients with long COVID
-
Support patients in hospital this Christmas and the staff looking after them by donating to our UCLH Charity Gift of Giving Appeal.
-
Volunteers are a highly valued part of the team at UCLH. Volunteering is a great way of giving back, doing something different and get some experience. Roles tend to be for a minimum of half a day a week for 6 months. For most of our roles you don’t necessarily need have to have prior experience as the key things we are looking for are great people skills and an ability to give us a regular commitment.
-
The Chartered Society of Physiotherapy (CSP) has announced that it will take industrial action on Thursday 26 January. As a result, its members that work at UCLH will be on strike on this day. CSP members will also be taking strike action on Thursday 9 Feb, though we are yet to hear if this will take place at UCLH.
-
Alternatives to Accident and Emergency (A&E) and attending the Emergency Department (Casualty) at UCLH
File results
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer